NCT00212862View on ClinicalTrials.gov

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

CompletedOBSERVATIONAL
Enrollment

2,130

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
AnemiaCancer
Interventions
OTHER

Patients with chemotherapy induced anemia

Physicians are instructed to continue to treat all patients according to their own best clinical judgment, but to submit information on the parameters and outcomes of this treatment to the database. Patients will have to fill the questionaire at the time of enrollment and baseline.

All Listed Sponsors
lead

Ortho Biotech Products, L.P.

INDUSTRY

NCT00212862 - Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia | Biotech Hunter | Biotech Hunter